在治疗Lenvatinib后的肝细胞癌患者中,基于炎症的不同预后值的比较
Wei-Jie Wu1,2,3, Ze-Yu Wu1,2,3, Dan-Dan Hu1,2,3
1Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou 510060, Guangdong Province, China.
World journal of gastroenterology
|January 2, 2026
概括
No abstract available in PubMed .
更多相关视频
08:56Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
54.3K
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
8.6K
